background
cinnamon
bark
one
popular
herbal
ingredi
tradit
orient
medicin
possess
divers
pharmacolog
activ
includ
antibacteri
antivir
anticanc
properti
goal
studi
investig
vivo
vitro
inhibitori
effect
cinnamon
water
extract
cwe
lipopolysaccharid
lp
induc
tumor
necrosi
factor
tnf
underli
intracellular
mechan
method
cwe
oral
administr
mice
day
prior
intraperiton
inject
lp
serum
level
interleukin
il
determin
hour
lp
stimul
periton
macrophag
thioglycollateinject
mice
isol
assay
viabil
cytokin
express
signal
molecul
upon
lp
stimul
cwe
fraction
accord
molecular
size
level
total
polyphenol
biolog
activ
fraction
measur
result
oral
administr
cwe
mice
significantli
decreas
serum
level
cwe
treatment
vitro
decreas
mrna
express
cwe
block
lpsinduc
degrad
well
activ
jnk
furthermor
sizebas
fraction
cwe
show
observ
inhibitori
effect
cwe
vitro
occur
fraction
contain
highest
level
total
polyphenol
conclus
treatment
cwe
decreas
lpsinduc
serum
vitro
inhibit
gene
cwe
may
occur
via
modul
degrad
jnk
activ
result
also
indic
observ
antiinflammatori
action
cwe
may
origin
presenc
polyphenol
bark
cinnamon
use
spice
tea
also
one
key
compon
herbal
remedi
common
cold
cardiovascular
diseas
chronic
gastrointestin
gynecolog
disord
orient
herbal
medicin
accordingli
extens
studi
pharmacolog
activ
cinnamon
bark
conduct
indic
cinnamon
bark
involv
vast
rang
patholog
physiolog
event
instanc
essenti
oil
waterbas
extract
cinnamon
shown
effect
pathogen
microb
virus
variou
type
tumor
cell
line
furthermor
also
report
cinnamon
bark
reduc
level
serum
glucos
enhanc
insulinregul
glucos
util
vivo
inflamm
protect
respons
purpos
remov
exogen
endogen
harm
substanc
produc
injuri
stimuli
part
heal
process
wound
tissu
sinc
proinflammatori
cytokin
tumor
necrosi
factoralpha
interleukin
il
lipid
mediat
proteas
oxid
produc
typic
respons
caus
damag
normal
tissu
regardless
inflammatori
respons
trigger
substanc
involv
inflammatori
respons
need
tightli
regul
scaveng
reaction
delay
inflammatori
respons
may
evolv
varieti
chronic
inflammatori
diseas
atherosclerosi
rheumatoid
arthriti
asthma
neurodegen
diseas
vast
number
molecular
studi
identifi
sever
target
molecul
involv
inflammatori
chang
antiinflammatori
drug
current
use
suppress
biosynthesi
inflammatori
mediat
mention
earlier
previou
studi
indic
major
pharmacolog
activ
cinnamon
bark
antibacteri
antiinflammatori
antivir
anticanc
effect
deriv
essenti
oil
cinnamaldehyd
howev
sinc
cinnamon
bark
typic
use
form
water
extract
volatil
ingredi
seldom
found
like
establish
pharmacolog
activ
cinnamon
bark
depend
mixtur
compris
varieti
watersolubl
compon
therebi
ensur
safeti
tradit
remedi
recent
found
cinnamon
bark
water
extract
cwe
elev
glucos
uptak
promot
insulin
sensit
inhibit
angiogenesi
block
vascular
endotheli
growth
factor
signal
result
indic
observ
pharmacolog
activ
may
origin
polyphenol
compound
cwe
studi
investig
vivo
vitro
effect
cwe
lipopolysaccharid
lp
induc
underli
intracellular
mechan
also
fraction
cwe
accord
molecular
size
determin
whether
exist
posit
correl
antiinflammatori
activ
cwe
amount
polyphenol
compound
cinnamon
bark
cinnamomi
cassia
p
resl
vietnames
origin
purchas
omni
herb
daegu
south
korea
plant
identifi
professor
choi
depart
herbolog
kyung
hee
univers
voucher
specimen
sampl
deposit
laboratori
herbolog
kyung
hee
univers
plant
pulver
soak
one
volum
water
hour
room
temperatur
dissolv
sonic
hour
extract
filter
evapor
use
freez
dryer
eyela
japan
yield
cwe
size
fraction
g
cwe
dissolv
ml
distil
water
fraction
collect
use
kda
amicon
ultra
centrifug
filter
devic
millipor
ireland
yield
low
molecular
weight
mw
fraction
kda
middl
mw
fraction
kda
kda
high
mw
fraction
kda
cwe
respect
final
sampl
dissolv
pb
steril
pass
syring
filter
eightweekold
male
balbc
mice
purchas
korean
branch
tacon
samtaco
osan
korea
fed
rodent
chow
water
ad
libitum
temperatureand
humiditycontrol
pathogenfre
anim
facil
medic
center
kyung
hee
univers
hospit
mice
maintain
accord
guid
care
use
laboratori
anim
issu
us
nation
research
council
protocol
approv
kyung
hee
univers
medic
center
institut
anim
care
use
committe
vivo
lp
inject
cwe
mgkg
bodi
weight
given
mice
via
oral
gavag
day
control
mice
receiv
equal
volum
normal
salin
experiment
period
group
consist
mice
day
lp
serotyp
sigma
st
loui
mo
usa
mgkg
inject
intraperiton
hour
blood
sampl
blood
obtain
cardiac
punctur
refer
drug
dexamethason
sigma
mgkg
inject
intraperiton
hour
lp
inject
blood
sampl
centrifug
g
min
serum
sampl
obtain
store
use
use
vitro
cultur
macrophag
normal
mice
inject
intraperiton
ml
steril
thioglycol
medium
bd
franc
macrophag
collect
three
day
later
periton
gavag
cold
dulbecco
modifi
eagl
medium
dmem
recov
periton
fluid
wash
centrifug
cell
resuspend
dmem
fetal
bovin
serum
incub
hour
co
nonadher
cell
remov
cell
viabil
determin
use
mtt
method
macrophag
seed
plate
treat
cwe
presenc
absenc
lp
hour
ten
microlit
mtt
solut
mgml
sigma
ad
well
hour
incub
media
aspir
dimethyl
sulfoxid
dmso
sigma
ad
optic
densiti
read
nm
use
micropl
reader
molecular
devic
sunnyval
ca
usa
periton
macrophag
seed
plate
pretreat
cwe
hour
stimul
ngml
lp
hour
total
rna
isol
use
rneasi
mini
kit
qiagen
germani
cdna
reversetranscrib
use
superscript
iii
revers
transcriptas
invitrogen
carlsbad
ca
usa
dilut
cdna
mix
power
sybr
green
pcr
master
mix
appli
biosystem
foster
citi
ca
usa
pmol
primer
gapdh
follow
forward
revers
primer
sequenc
use
forward
atg
atc
gcg
gac
gtg
revers
agg
gcc
tgg
agt
tct
gga
gapdh
forward
ggc
atg
gac
tgt
ggt
cat
revers
ttc
acc
acc
atg
gag
aag
amplif
cdna
perform
triplic
use
stepon
realtim
pcr
system
appli
biosystem
initi
heat
denatur
min
pcr
condit
set
min
cycl
pcr
correspond
mrna
sampl
without
rt
includ
neg
control
quantif
cdna
copi
number
determin
accord
manufactur
protocol
gapdh
gene
use
endogen
control
level
cytokin
serum
cell
supernat
measur
enzymelink
immunosorb
assay
elisa
accord
manufactur
protocol
bd
pharmingen
usa
periton
macrophag
seed
pretreat
cwe
hour
stimul
lp
min
cell
rins
cold
pb
lyse
ice
ml
ripa
buffer
mm
trishcl
ph
mm
nacl
mm
edta
mm
naf
triton
contain
phosphatas
inhibitor
cocktail
sigma
proteas
inhibitor
cocktail
roch
diagnost
mannheim
germani
centrifug
g
min
supernat
collect
protein
concentr
determin
use
bradford
protein
assay
reagent
biorad
usa
sampl
dilut
sodium
dodecyl
sulfat
sd
buffer
boil
min
sampl
separ
sdspolyacrylamid
gel
transfer
polyvinyliden
fluorid
membran
membran
block
skim
milk
trisbuff
salin
tween
tbst
hour
membran
incub
ikk
tubulin
santa
cruz
biotechnolog
ca
usa
phosphoikk
phosphojnk
jnk
dilut
skim
milk
tbst
overnight
blot
wash
tbst
incub
hour
antirabbit
horseradish
peroxidaseconjug
antibodi
immunoreact
band
visual
chemiluminesc
use
ecl
ge
healthcar
littl
chalfont
buckinghamshir
uk
accord
manufactur
instruct
total
polyphenol
cwe
sizebas
fraction
determin
folinciocalteau
fc
colorimetri
describ
previous
gallic
acid
solut
use
calibr
standard
curv
twenti
microlit
fraction
total
cwe
ml
water
incub
fc
reagent
sigma
min
room
temperatur
three
hundr
microlit
sodium
carbon
solut
use
quench
fc
reagentmedi
reaction
form
chromogen
read
absorb
nm
concentr
polyphenol
calcul
gallic
acid
equival
per
gram
extract
vivo
data
present
mean
sem
statist
differ
among
mean
multipl
group
determin
use
oneway
anova
follow
scheff
test
vitro
data
present
mean
sd
differ
two
mean
assess
use
nonpair
student
ttest
calcul
carri
use
spss
version
p
valu
less
consid
signific
lp
endotoxin
origin
cell
wall
gramneg
bacteria
stimul
express
monocyt
macrophag
cytokin
provid
protect
effect
bodi
induc
blood
clot
leukocyt
recruit
activ
adapt
immun
larg
quantiti
cytokin
serum
result
provok
dissemin
intravascular
coagul
multipl
organ
failur
septic
shock
first
test
whether
cwe
treatment
affect
system
inflammatori
respons
lp
stimul
end
cwe
oral
administr
mice
day
intraperiton
inject
lp
releas
serum
measur
elisa
base
previou
studi
dose
mgkg
chosen
oral
administr
dexamethason
use
refer
drug
compar
suppress
activ
cwe
presenc
lp
serum
level
significantli
reduc
mgkg
dose
higher
dose
mgkg
show
lesser
reduct
lower
dose
point
statist
signific
figur
pattern
observ
previou
work
dosedepend
reduct
serum
occur
mgkg
cwe
case
dosedepend
decreas
occur
mgkg
dosag
group
although
latter
group
reach
statist
signific
mgkg
group
show
higher
level
control
group
seem
unidentifi
compound
beyond
critic
level
may
interfer
antiinflammatori
compon
cwe
next
want
examin
vitro
effect
cwe
macrophag
major
cell
sourc
use
periton
macrophag
isol
thioglycollateinject
mice
determin
rang
cwe
concentr
repres
cytotox
activ
use
mtt
method
concentr
cwe
cytotox
periton
macrophag
treat
without
lp
figur
mani
herbal
water
extract
contain
polysaccharid
induc
secret
nonstimul
macrophag
vitro
found
treatment
cwe
alon
rang
stimul
releas
media
concentrationdepend
manner
figur
phenomenon
must
due
presenc
water
solubl
polysaccharid
cwe
subsequ
examin
effect
cwe
figur
vitro
effect
cwe
lpsinduc
degrad
map
kinas
activ
periton
macrophag
pretreat
indic
concentr
cwe
h
stimul
lp
min
phosphoikk
phosphojnk
jnk
whole
protein
extract
examin
western
blot
analysi
tubulin
use
intern
control
one
five
experi
shown
lpsstimul
secret
appar
decreas
secret
cwe
figur
howev
mrna
express
h
lp
challeng
decreas
cell
treat
cwe
figur
despit
inhibit
lpsinduc
transcript
unab
level
supernat
must
caus
prior
exposur
cell
cwe
vitro
effect
cwe
activ
jnk
erk
upon
lp
stimul
absenc
stimuli
act
inhibitor
block
nuclear
transloc
mask
nuclear
local
signal
upon
inflammatori
stimul
subject
phosphoryl
mediat
upstream
kinas
kinas
ikk
subsequ
releas
follow
phosphorylationinduc
proteosom
degrad
test
effect
cwe
degrad
min
lp
stimul
time
cours
studi
activ
lpsstimul
macrophag
show
phosphoryl
reach
peak
min
lp
stimul
disappear
min
complet
degrad
occur
within
min
expect
almost
complet
loss
well
identifi
macrophag
treat
lp
alon
figur
cwe
dose
inhibit
degrad
although
still
detect
phosphoryl
ikk
affect
result
strongli
indic
inhibitori
effect
cwe
signal
may
occur
downstream
phosphoryl
mitogenactiv
protein
map
kinas
resid
cytoplasm
mammalian
cell
relay
extracellular
signal
nucleu
variou
signal
transduct
pathway
jnk
repres
famili
map
kinas
play
critic
role
lpsinduc
cytokin
gene
express
test
whether
cwe
inhibit
activ
jnk
min
lp
stimul
jnk
phosphoryl
reduc
concentr
test
phosphoryl
erk
inhibit
cwe
impli
differ
constitu
cwe
may
act
pathway
figur
taken
togeth
result
show
inhibit
occur
upstream
map
kinas
inhibitori
effect
cwe
fraction
contain
highmolecularweight
compound
signal
molecul
lpsstimul
macrophag
sinc
effect
oral
dose
cwe
rel
low
reason
specul
natur
activ
compon
might
smallmolecul
compound
thu
separ
cwe
low
mw
fraction
kda
middl
mw
fraction
kda
kda
high
mw
fraction
kda
sinc
insulinlik
antioxid
activ
cwe
origin
polyphenol
compound
want
determin
polyphenol
content
fraction
shown
tabl
highest
concentr
total
polyphenol
observ
high
mw
fraction
tenfold
low
middl
mw
fraction
next
base
fraction
yield
ratio
rel
total
cwe
low
middl
high
mw
fraction
ad
macrophag
effect
signal
molecul
examin
suppress
degrad
phosphoryl
jnk
erk
detect
cell
treat
high
mw
fraction
figur
find
indic
inhibitori
activ
cwe
vitro
deriv
polyphenolrich
fraction
studi
present
vivo
vitro
evid
cwe
inhibit
express
addit
lpsinduc
degrad
map
kinas
phosphoryl
macrophag
strongli
inhibit
polyphenolrich
cwe
fraction
macrophag
phagocyt
cell
play
critic
role
clear
foreign
materi
invad
bacteria
cellular
debri
produc
tissu
injuri
phagocyt
macrophag
contain
varieti
patternrecognit
receptor
prr
specif
recogn
foreign
organ
modifi
self
ligand
tolllik
receptor
tlr
complement
receptor
scaveng
receptor
affili
member
prr
famili
among
lp
use
tlrmediat
signal
pathway
map
kinas
stimul
macrophag
oral
administr
cwe
decreas
serum
level
lpsinduc
antiinflammatori
activ
attenu
high
dose
group
clinic
set
cwe
use
combin
herbal
agent
thu
differ
result
could
produc
howev
experiment
data
impli
use
singularli
antiinflammatori
activ
cwe
subject
dose
rang
chronic
inflammatori
respons
found
autoimmun
diseas
metabol
diseas
exhibit
common
characterist
process
macrophag
initi
activ
interferon
ifn
helper
cell
subsequ
stimul
macrophag
releas
inflammatori
cytokin
togeth
previou
find
cwe
prevent
cell
secret
current
studi
clearli
show
cwe
abl
interfer
chronic
activ
macrophag
inhibitori
effect
cwe
signal
pathway
mediat
map
kinas
occur
polyphenolrich
high
mw
fraction
increas
evid
polyphenol
exert
antiinflammatori
effect
sinc
cwe
rich
polyphenol
flavonoid
tannin
antiinflammatori
effect
cwe
may
origin
partli
polyphenol
compound
although
high
mw
fraction
account
yield
cwe
polyphenol
content
four
time
cwe
high
mw
fraction
may
contain
polyphenol
conjug
polysaccharid
tannin
procyanidin
known
condens
tannin
consist
oligom
polym
epi
catechin
higher
degre
polymer
procyanidin
exhibit
stronger
inhibit
macrophag
activ
therefor
conceiv
polyphenolrich
high
mw
fraction
cwe
may
contain
antiinflammatori
compound
play
major
role
suppress
lpsinduc
map
kinas
signal
pathway
studi
requir
examin
whether
macromolecular
polyphenol
cwe
exert
antiinflammatori
effect
anim
model
summari
oral
treatment
cwe
decreas
lpsinduc
releas
serum
cwe
inhibit
degrad
map
kinas
activ
lpsstimul
macrophag
vitro
particular
inhibitori
activ
cwe
vitro
occur
polyphenolrich
high
molecular
weight
fraction
